CoChat

CFH and ARMS2 genetic risk determines progression to neovascular age-related macular degeneration after antioxidant and zinc supplementation

Open access
Vavvas, Demetrios G., Small, Kent W., Awh, Carl C., Zanke, Brent W., Tibshirani, Robert J., Kustra, Rafal · 2018 · Proceedings of the National Academy of Sciences
Cited by 67

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Significance: Age-related macular degeneration (AMD) is the leading cause of severe vision loss in the elderly and has major economic and quality-of-life impact. Prophylactic high-dose zinc and antioxidant supplements treatments are typically recommended with the assumption of homogeneously distributed benefit and risk of developing neovascular AMD. We show that individual variation at complement factor H and age-related maculopathy susceptibility 2 , genes which predispose to AMD, also determines the effectiveness of nutritional prophylaxis. Some individuals paradoxically experience worsening disease with treatment, while others experience greater than average benefit. These divergent responses are difficult to identify when treatment effects have long latency. Understanding individual variations in prophylactic treatment response should inform future research and optimize health outcomes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.1718059115

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Research works printed but not linked: 27

  1. 10.1186/s40662-016-0063-5 · DOI · Paper page
  2. 10.1016/j.ajo.2012.04.017 · DOI
  3. 10.1001/jamaophthalmol.2015.18 · DOI
  4. 10.1167/iovs.11-8657 · DOI · Paper page
  5. 10.1016/j.ophtha.2013.01.021 · DOI · Paper page
  6. 10.1136/bjophthalmol-2016-308624 · DOI · Paper page
  7. 10.1016/j.ophtha.2014.07.049 · DOI
  8. 10.1016/j.ophtha.2013.07.039 · DOI
  9. 10.1214/aos/1176344552 · DOI · Paper page
  10. 10.1016/j.jtcvs.2006.02.002 · DOI
  11. 10.1038/nmeth.3414 · DOI · Paper page
  12. 10.1016/j.ophtha.2014.10.023 · DOI
  13. A Henning AREDS dbGAP Data Tables: A User’s Guide. Available at https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/GetPdf.cgi?id=phd001552.1. Accessed November 13 2017. (2009).
  14. 10.1007/978-1-4899-4541-9 · DOI · Paper page
  15. 10.1056/NEJMsa0907130 · DOI · Paper page
  16. 10.1016/j.cccn.2005.04.002 · DOI · Paper page
  17. 10.1002/sim.5681 · DOI · Paper page
  18. A Domalpally, , Peripheral retinal changes associated with age-related macular degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 report number 12 by the Age-Related Eye Disease Study 2 Optos PEripheral RetinA (OPERA) study research group. Ophthalmology; Writing Committee for the OPTOS PEripheral RetinA (OPERA) study (Ancillary Study of Age-Related Eye Disease Study 2) 124, 479–487 (2017). · DOI
  19. 10.1016/j.ophtha.2015.03.005 · DOI
  20. 10.1016/j.ophtha.2007.06.021 · DOI
  21. 10.1167/iovs.08-2514 · DOI · Paper page
  22. 10.1016/j.exer.2006.12.015 · DOI
  23. 10.1016/j.imbio.2011.10.003 · DOI · Paper page
  24. 10.1042/BST0380894 · DOI
  25. 10.1016/j.jmb.2011.03.006 · DOI · Paper page
  26. 10.1016/j.jmb.2008.10.030 · DOI
  27. 10.1074/jbc.M114.605691 · DOI

Cited by

See all 67

Metadata

Authors
Vavvas, D. G., Small, K. W., Awh, C. C., Zanke, B. W., Tibshirani, R. J., & Kustra, R.
Venue
Proceedings of the National Academy of Sciences
Published
2018-01-08
Volume
115
Issue
4
Pages
E696-E704
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2782610741
Cited by
67
References
10
FWCI
7.56
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: CFH and ARMS2 genetic risk determines progression to neovascular age-related macular degeneration after antioxidant and zinc supplementation. https://app.cochat.ai/papers/10.1073/pnas.1718059115
The paper
Vavvas, D. G., Small, K. W., Awh, C. C., Zanke, B. W., Tibshirani, R. J., & Kustra, R. (2018). CFH and ARMS2 genetic risk determines progression to neovascular age-related macular degeneration after antioxidant and zinc supplementation. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1718059115

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.